Commercial launch is on-track for ZUSDURI™, the first and only FDA-approved medication for adults with recurrent low-grade intermediate-risk ...

Explore the latest tech laptops for STEM students designed specifically to handle the demanding software, coding, and ...

New formulation of its widely-used U.S. market-leading PSMA PET imaging agent combines thediagnostic performance of PYLARIFY® (piflufolastat F 18) with the potential for la ...

LAFAYETTE, LA / ACCESS Newswire / March 4, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a ...

We released our results and are hosting today's call to discuss Riskified Ltd.'s financial results for the fourth quarter and full year 2025. Our earnings materials, including a replay of today's ...

There's a seemingly never-ending selection to choose from when it comes to the top streaming services, but the best Disney Plus bundles are designed to get you as much as possible under one discounted ...

Sapiens' market-leading, award-winning IDITSuite will optimise and automate CZ's processes for their customers and employees through three main drivers: automation, uniformity, and standardisation ...

Kinaxis Inc. ( KXS:CA) Q4 2025 Earnings Call March 5, 2026 8:30 AM EST Good morning, and welcome to the Kinaxis Inc. Fiscal 2025 Fourth Quarter and Year-end Results Conference Call. [Operator ...

Resident Evil Requiem (2026) hasn’t been out for more than a week, and there’s already a basic PC VR mod waiting in the wings. While Capcom may have “no plans” for VR support, VR modder ‘Praydog’ has ...

Commercial launch is on-track for ZUSDURI, the first and only FDA-approved medication for adults with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC); net sales ...

Aecon Group Inc. (TSX: ARE) (“Aecon” or the “Company”) today reported results for the fourth quarter and year-end 2025, including record full year ...

The MarketWatch News Department was not involved in the creation of this content.-- FY 2025 revenue increased to $176.2 million, exceeding the high end of previous guidance -- Lif ...